Sawicki, Gregory S.

Measuring the Transition Readiness of Youth with Special Healthcare Needs: Validation of the TRAQ—Transition Readiness Assessment Questionnaire

Sawicki, G. S., Lukens-Bull, K., Yin, X., Demars, N., Huang, I.-C., Livingood, W., Reiss, J., & Wood, D. (2011) · Journal of Pediatric Psychology

Adolescent and Pediatric HealthcareChildhood Cancer Survivors' Quality of Life

Cited by 592

High treatment burden in adults with cystic fibrosis: challenges to disease self-management

Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesNursing care and research

Cited by 498

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Volkova, N., Moy, K., Evans, J., Campbell, D., Tian, S., Simard, C., Higgins, M., Konstan, M. W., Sawicki, G. S., Elbert, A., et al. (2020) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 258

Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data

Sawicki, G. S., McKone, E. F., Pasta, D. J., Millar, S. J., Wagener, J. S., Johnson, C. A., & Konstan, M. W. (2015) · American Journal of Respiratory and Critical Care Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 236

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor

Bessonova, L., Volkova, N., Higgins, M., Bengtsson, L., Tian, S., Simard, C., Konstan, M. W., Sawicki, G. S., Sewall, A., Nyangoma, S., et al. (2018) · Thorax

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 214

Transition care: future directions in education, health policy, and outcomes research

Sharma, N., O’Hare, K., Antonelli, R. C., & Sawicki, G. S. (2014) · Academic Pediatrics

Adolescent and Pediatric HealthcareHospital Admissions and Outcomes

Cited by 156

Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis

Sawicki, G. S., Rasouliyan, L., McMullen, A. H., Wagener, J. S., McColley, S. A., Pasta, D. J., & Quittner, A. L. (2011) · Pediatric Pulmonology

Cystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 106

Decreased survival in cystic fibrosis patients with a positive screen for depression

Schechter, M. S., Ostrenga, J. S., Fink, A. K., Barker, D. H., Sawicki, G. S., & Quittner, A. L. (2021) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesCardiac Health and Mental Health

Cited by 71

EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS

Lee, T., Sawicki, G. S., Altenburg, J., Millar, S. J., Geiger, J. M., Jennings, M. T., Lou, Y., McGarry, L. J., Van Brunt, K., & Linnemann, R. W. (2023) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 56

Risk factors for gaps in care during transfer from pediatric to adult cystic fibrosis programs in the United States

Sawicki, G. S., Ostrenga, J., Petren, K., Fink, A. K., D’Agostino, E., Strassle, C., Schechter, M. S., & Rosenfeld, M. (2018) · Annals of the American Thoracic Society

Adolescent and Pediatric HealthcareCystic Fibrosis Research Advances

Cited by 53